BIS Research

DECEMBER 20, 2018

Although, the vaccine market is small as compared to the pharmaceutical market in the healthcare industry but has showcased a better growth rate than the pharmaceutical market. billion in 2017 and is expected to reach $103.57 billion by 2028, growing at a CAGR of 11% during the forecast period (2018 – 2028).

Pharmaceutical 40

Pharmaceutical Globalization Research Market Intelligence 40

Contify

AUGUST 21, 2019

Contify, an AI-enabled market and competitive intelligence solutions provider, announced today that it has successfully deployed its platform to generate customized daily competitive intelligence reports for a leading pharma company focused on the development of novel drugs to treat rare diseases.

Competitive Intelligence 40

Competitive Intelligence Pharmaceutical Competitive Intelligence 40

BIS Research

MAY 17, 2019

The introduction of technologies such as artificial intelligence and machine learning have transformed several sectors, including the robotics and UAV industry. Research and development activities in robotics undertaken by several organizations have led to the development of new-age robots performing functions better than humans.

Pharmaceutical 40

Pharmaceutical Marketing Marketing Commerce 40

Sedulo

MARCH 15, 2023

2 Next, we grouped pharmaceutical sponsors/collaborators by their Scrip 100 industry rankings into two groups: top 20 pharma and all other pharma. Our Approach to this Analysis: We started by analyzing pharma-sponsored clinical trials, 1 initiated between 2018 and 2022, for only unapproved primary immuno-oncology (IO) drugs.

Biotech 52

Biotech Competitive Landscape Pharmaceutical Benchmarking 52

BIS Research

NOVEMBER 29, 2018

Over the past couple of years, research on various types of sophisticated drugs is being carried out for the treatment of a variety of diseases and biologics is one of them. The area of focus for these companies is extensive research and development programs, which can help develop best-in-class therapies for the novel patient experience.

Pharmaceutical 40

Pharmaceutical Globalization Research Market Intelligence 40

BIS Research

MARCH 19, 2019

This approach enables providers to gather data about the molecular mechanisms of an individual being tested, which further enables researchers to develop targeted therapies and preventive strategies. The precision therapeutics is segmented into clinical trials, cell therapy, drug discovery and research, and gene therapy.

Globalization 64

Globalization Biotech Marketing Marketing 64

BIS Research

APRIL 9, 2019

Owing to the applications of microbiology testing across various industries, such as pharmaceutical, food and beverage, dairy, agriculture and fermentation, paper, biotechnology, and water & environmental industry, the global industrial microbiology market is projected to witness significant growth during the forecast period, 2019-2028.

Matrix 40

Matrix Pharmaceutical Globalization Analysis 40

Alpha Sense BI

JANUARY 11, 2024

This past September, Danish pharmaceutical company Novo Nordisk surpassed LVMH to become the most valuable listed company in Europe due to a surge in demand for its highly efficient diabetes and weight-loss medications, Ozempic and Wegovy. Competition is brewing, setting the stage for a landscape that will rapidly evolve in 2024 and beyond.

Loss 52

Loss Pharmaceutical Competitive Landscape Research 52

Alpha Sense BI

JULY 14, 2023

What to Look for in a Competitive Intelligence Tool To find the best competitive intelligence tool for your business, you need to know what to look for and what questions to ask during your research. What artificial intelligence (AI) capabilities does it provide, if any?

Competitive Intelligence 52

Competitive Intelligence Competitive Battlecard Intelligence 52

BIS Research

MARCH 11, 2019

According to the latest market intelligence report by BIS Research titled Global Cancer Immunotherapy Market – Analysis and Forecast (2018-2028), the market was valued at $39.86 billion in 2017 and is expected to witness significant growth at a CAGR of 14.14% during the forecast period (2018-2028), to reach $170.70

Pharmaceutical 40

Pharmaceutical Marketing Marketing Analysis 40

Alpha Sense BI

APRIL 28, 2023

Under these programs, “prescription drug spending accounts for a significant portion of national pharmaceutical spending, which totaled $577 billion in 2021, and supply-chain complexity has complicated efforts to track the flow of these dollars.” So maybe the PBMs are to blame.

Management 52

Management IT Pharmaceutical Finance 52

Netbasequid

JUNE 29, 2022

The point is whether it’s Fauci, Longmire or even Chief Medical Microsoft scientist and researcher, Junaid Bajwa , knowing what healthcare KOLs have to say is extremely beneficial. In fact, they could be hospital executives, health system directors, researchers like Dr Tedros Adhonom Ghebrevesus , patient advocacy group members and more.

Pharmaceutical 52

Pharmaceutical Hospitals Win Innovation 52

Alpha Sense BI

FEBRUARY 3, 2023

As ESG investing becomes increasingly important to a company’s vitality in our volatile market, future compliance and audit requirements will likely follow, making digitization essential to scale resources and outcomes organization-wide. timber, natural pharmaceuticals) and services (i.e., AlphaSense is that and more.

Finance 98

Finance Due Diligence Banking Pharmaceutical 98

Netbasequid

JULY 16, 2021

And researching older influencers with authentic and relevant pain challenges will be a must for brands. They have the longest laundry list of painful ailments that CBD targets and anything that relieves pain while creating a smaller pharmaceutical footprint for them is a win-win. View this post on Instagram.

Pharmaceutical 98

Pharmaceutical Win Gaming Travel 98

Alpha Sense BI

DECEMBER 5, 2023

But when it comes to broker research, most professionals today are unaware of the insights these reports hold. In fact, most market intelligence platforms lack access to this form of intel, not only leaving blind spots in your research, but also a window for you to overlook lucrative market opportunities.

Research 59

Research SWOT Commerce Pharmaceutical 59

ArchIntel

MARCH 17, 2021

DuBell began his career at Kantar as a research analyst in 2007. He led the publishing of an internationally distributed multi-client marketing research report for almost four years. At Planet Biotechnology, he supervised a group of research associates and designed DNA constructs for research and production efforts.

Pharmaceutical 104

Pharmaceutical Competitive Competitive Intelligence Profiling 104

Alpha Sense BI

APRIL 26, 2024

Competitor monitoring transcends industries and equips every kind of business—from startups to global corporations—with the intelligence they need to navigate complex markets and outmaneuver their competition. It’s supported by advanced AI features for added scope, speed, and accuracy—all in one centralized platform.

Battlecard 52

Battlecard Startups Competitor Analysis Competitive Intelligence 52

Alpha Sense BI

JANUARY 27, 2023

From billion-dollar funding for research on widespread health adversities to manufacturing new technologies to address them, the virus has ramped up lucrative investment opportunities in nearly every industry sector. Since the onset of the COVID-19 pandemic, the pharma industry has experienced rapid, radical change.

Pharmaceutical 98

Pharmaceutical Research Capital Intelligence 98

Alpha Sense BI

OCTOBER 5, 2023

And today, we’re proud to say that AlphaSense is the world’s most robust market intelligence search platform for professionals across all industries. As we look to the future, we’re excited about how we’ll keep our customers ahead of the market through innovations in generative AI (genAI). Our solution?

Intelligence 105

Intelligence Intelligence Market Intelligence Pharmaceutical 105

Alpha Sense BI

OCTOBER 13, 2023

Regardless of this divergence in opinion, weight loss drugs like Ozempic, Wegovy, and Mounjaro offer a promising opportunity in the healthcare and pharmaceutical market, with innovation and research continually striving to provide safer and more effective solutions for those in need. And the market is just huge.”

Loss 52

Loss Pharmaceutical Travel Research 52

Alpha Sense BI

JANUARY 25, 2023

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Alpha Sense BI

SEPTEMBER 1, 2023

President Biden’s Inflation Reduction Act (IRA) is making history within the pharmaceutical space: for the first time, Medicare will negotiate the prices of prescription drugs. laws had prohibited Medicare from negotiating pharmaceutical prices as part of its prescription drug program that began about 20 years ago.

Pharmaceutical 52

Pharmaceutical Biotech Market Intelligence Competitive 52

Alpha Sense BI

DECEMBER 12, 2023

Industry nuances, company culture, leadership styles, competitor interactions—these are facets you can’t necessarily uncover by researching numbers and figures, yet they significantly impact whether or not two companies have the right synergies to succeed. Navigating the cultural challenges around M&A integration is a delicate process.

Due Diligence 52

Due Diligence Primary Research Competitive Intelligence Market Intelligence 52

FedSavvy

APRIL 25, 2023

Department of State (DOS), and commercial clients in the pharmaceutical, financial services and education sectors. Datastrong enhanced Smartronix’s cloud capabilities and expanded solutions in enterprise analytics, data science, and data engineering and management. Datastrong also brought new federal clients within the U.S.

Intellectual Property 130

Intellectual Property Pharmaceutical Intelligence Intelligence 130

Alpha Sense BI

DECEMBER 20, 2022

For biological medicines, studies have revealed research and development costs at $985 million to bring a single product to market. Research has revealed growing trust among physicians and patients alike with biosimilars thanks to education campaigns and improved regulatory guidance from the Food and Drug Administration. . “As

Marketing 98

Marketing Marketing Pharmaceutical Competitive 98

Alpha Sense BI

APRIL 12, 2024

AlphaSense, a leading artificial intelligence (AI)-based market intelligence platform , offers proprietary Expert Insights through its extensive expert transcript library and Expert Call Services. Similarly, expert calls fill particular roles. If you’re going to force me into TPU, that’s like locking me in.

Primary Research 52

Primary Research Advantage Advantage Research 52

Alpha Sense BI

DECEMBER 15, 2023

According to Precedence Research , the AI market within the healthcare sector is projected to surpass $20.6 In silico trials, powered by AI simulations, researchers can forecast the efficacy and safety profiles of new drugs before they reach human trials. billion in 2023.

Pharmaceutical 52

Pharmaceutical Algorithm Predictive Analytics Research 52

Alpha Sense BI

MARCH 13, 2024

This emerging trend is allowing pharmaceutical companies—large and small—to distinguish themselves among competitors and investors as they pioneer advancements fueled by AI. The ability to bring drugs and therapies to market sooner, with less intrinsic cost, ultimately leads to stronger valuations and greater stakeholder value.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

MARCH 28, 2023

These first-hand perspectives are a critical addition to the secondary research that most professionals rely on in their market research, landscaping, and monitoring. Which company provides access to the most in-depth, varied expertise that will ultimately eliminate blind spots in your research?

Value Chain 52

Value Chain Biotech Research Pharmaceutical 52